Cargando…
Metabolic Comorbidities and Risk of Development and Severity of Drug-Induced Liver Injury
The incidence and rates of diagnosis of drug-induced liver injury (DILI) have been increasing in recent years as findings from basic research and the examination of clinical databases reveal information about the clinical course, etiology, and prognosis of this complex disease. The prevalence of met...
Autores principales: | Li, Xu, Gao, Pujun, Niu, Junqi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6720367/ https://www.ncbi.nlm.nih.gov/pubmed/31531370 http://dx.doi.org/10.1155/2019/8764093 |
Ejemplares similares
-
Relationships between Metabolic Comorbidities and Occurrence, Severity, and Outcomes in Patients with Acute Pancreatitis: A Narrative Review
por: Li, Xu, et al.
Publicado: (2019) -
Dyslipidemia is a Risk Factor for the Incidence and Severity of Drug-Induced Liver Injury (DILI): A Retrospective Population-Based Study in China
por: Li, Xu, et al.
Publicado: (2019) -
Increased red cell distribution width predicts severity of drug-induced liver injury: a retrospective study
por: Li, Xu, et al.
Publicado: (2021) -
Fatty liver increases gallstone disease risk in younger Chinese patients
por: Li, Xu, et al.
Publicado: (2019) -
Diabetes mellitus is a significant risk factor for the development of liver cirrhosis in chronic hepatitis C patients
por: Li, Xu, et al.
Publicado: (2017)